Nuclear Medicine
LINFOFAST
Name:
Linfofast ®
Active Principle:
Bovine Collagen Gelatin
Therapeutic Action:
It is indicated for scintigraphic visualization of lymphatic vessels and lymph node stations by means of static or dynamic lymphoscintigraphy or radioisotopic lymphography.
The static morphological study makes it possible to identify the functioning lymphatic vessels and the lymph node stations. It is used for the study of primary and secondary lymphedema of the upper and lower limbs, post-nodal dissection limb lymphedema in cancer patients, in acute bacterial lymphangitis or late sequelae, for the location of the sentinel node in the new conception of oncological surgery and decision-making in the subsequent treatment of the patient, be it radiant therapy or administration of cytostatics (chemical therapy).
The usual indications for scintigraphy in oncological pathologies are:
-Sentinel node in melanomas, breast cancer (internal mammary chain), cervical cancer, endometrial cancer, vulvar cancer and penile cancer.
-Lymphatic mapping.
-Sentinel nodebiopsy
-Radioguided surgery
Línea
Nuclear Medicine
Sublínea
SPECT Radiopharmaceuticals
LINFOFAST
Línea
Nuclear Medicine
Sublínea
SPECT Radiopharmaceuticals
LINFOFAST
Nuclear Medicine
LINFOFAST
Name:
Linfofast ®
Active Principle:
Bovine Collagen Gelatin
Therapeutic Action:
It is indicated for scintigraphic visualization of lymphatic vessels and lymph node stations by means of static or dynamic lymphoscintigraphy or radioisotopic lymphography.
The static morphological study makes it possible to identify the functioning lymphatic vessels and the lymph node stations. It is used for the study of primary and secondary lymphedema of the upper and lower limbs, post-nodal dissection limb lymphedema in cancer patients, in acute bacterial lymphangitis or late sequelae, for the location of the sentinel node in the new conception of oncological surgery and decision-making in the subsequent treatment of the patient, be it radiant therapy or administration of cytostatics (chemical therapy).
The usual indications for scintigraphy in oncological pathologies are:
-Sentinel node in melanomas, breast cancer (internal mammary chain), cervical cancer, endometrial cancer, vulvar cancer and penile cancer.
-Lymphatic mapping.
-Sentinel nodebiopsy
-Radioguided surgery
RELATED PRODUCTS
-
PSMA (R+D)
PSMA (R+D)It is indicated for the detection and evaluation of prostate cancer from the initial diagnosis to the monitoring of castration-resistant metastases. -
PYROPHOSPHATE
PYROPHOSPHATEIt is indicated for performing bone scintigraphy, detection of cardiac pathologies and "in vivo" and "in vitro" marking of erythrocytes. 1) In vivo, in vitro or in vivo/in vitro marking of red blood cells to... -
TECHNETIUM GENERATOR
TECHNETIUM GENERATORIt is indicated for obtaining a solution of Sodium Pertechnetate (Tc99m) ...